The presence of systemic inflammation in patients with advanced pancreatic cancer may point to possible resistance to CD40 agonists, according to findings from a new study.

Read more: https://www.docwirenews.com/docwire-pick/inflammation-may-provide-insights-into-treatment-resistance-in-pancreatic-cancer/